GFAP and Alzheimer disease: They successfully tested several markers (DCX, NeuN, PSA-NCAM, GFAP, PH3, Prox1, calretinin, βIII-tubulin, and calbindin) in healthy brains, and under pathological conditions in brains from patients with Alzheimer’s disease.